Strength30 mg
Formoral.solid
Adult dose and durationImmediate release (tablet, syrup or solution): 60-120 mg/day in 2 to 3 divided doses. Extended-release capsule: 75 mg once daily
Paediatric dose(Children 2-6 years: 7.5 mg three times daily. Children 6-12 years: 15 mg two to three times daily. Infants: the monograph gives 1.2-1.6 mg/kg without specifying per dose or per day, so the numeric fields are left null rather than guessed. Not for children under 2 years.)
Dose by age| 2 to 6 years: | 7.5 mg three times daily |
|---|
| 6 to 12 years: | 15 mg two to three times daily |
|---|
Dose sourceEgyptian National Drug Formulary - Respiratory 2026 (ambroxol monograph)
Why19 live products, and one of the most-dispensed cough preparations in Egypt. The formulary's oral indication is acute and chronic respiratory tract disorders with pathologically thickened mucus and impaired mucus transport. Included so a search does not come back empty, with the evidence limitation stated in the cautions.
Cautions- Acute bronchitis is viral and self-limiting. A mucolytic does not shorten it, and antibiotics are not indicated - the honest treatment is reassurance that a post-viral cough lasts 2-3 weeks.
- The evidence of benefit is modest and comes mainly from studies in chronic productive cough, not acute bronchitis.
- Rare but serious skin reactions have been reported with ambroxol - Stevens-Johnson syndrome, erythema multiforme and acute generalised exanthematous pustulosis. Stop at the first rash.
- The buccal spray and lozenges are local anaesthetics for sore throat - a different indication at a different dose from the oral mucolytic.
- Do not combine with the dextromethorphan already listed in the same row - suppressing a cough while thinning the sputum works against itself.